Karuna Therapeutics Inc
Change company Symbol lookup
Select an option...
KRTX Karuna Therapeutics Inc
SNSE Sensei Biotherapeutics Inc
ALGS Aligos Therapeutics Inc
SRRA Sierra Oncology Inc
ATOS Atossa Therapeutics Inc
OSMT Osmotica Pharmaceuticals PLC
SAND Sandstorm Gold Ltd
GRVI Grove Inc
STON Stonemor Inc
TK Teekay Corp
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Karuna Therapeutics Inc. is a clinical-stage biopharmaceutical company. The Company is focused on to create and deliver transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate, KarXT, is an oral modulator of muscarinic receptors that are located both in the central nervous system (CNS) and various peripheral tissues. It is initially developing KarXT, for the treatment of acute psychosis in patients with schizophrenia. The Company is developing a pipeline of therapeutic programs to address symptoms associated with schizophrenia and psychosis associated with Alzheimer’s disease (AD), as well as various forms of pain. KarXT is a combination of xanomeline and trospium. KarXT combines xanomeline, a muscarinic agonist, with trospium, a muscarinic antagonist, to stimulate muscarinic receptors in the CNS. It is advancing a pipeline of therapeutic programs to address the positive, negative and cognitive symptoms.

Price
Delayed
$123.87
Day's Change
-0.74 (-0.59%)
Bid
--
Ask
--
B/A Size
--
Day's High
125.49
Day's Low
121.22
Volume
(Light)

Today's volume of 28,078 shares is on pace to be much lighter than KRTX's 10-day average volume of 191,081 shares.

28,078

Thinking about trading options or stock in Nio, Applovin, Bilibili, Levi Strauss, or MicroStrategy?

9:31 am ET October 7, 2021 (PR Newswire) Print

InvestorsObserver issues critical PriceWatch Alerts for NIO, APP, BILI, LEVI, and MSTR.

https://mma.prnewswire.com/media/1333368/InvestorsObserver_Logo.jpg

Click a link below then choose between in-depth options trade idea report or a stock score report.

Options Report - Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.

Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.

-- NIO: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NIO&prnumber=100720213

-- APP: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=APP&prnumber=100720213

-- BILI: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=BILI&prnumber=100720213

-- LEVI: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=LEVI&prnumber=100720213

-- MSTR: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MSTR&prnumber=100720213

(Note: You may have to copy this link into your browser then press the [ENTER] key.)

https://c212.net/c/img/favicon.png?sn=CG32759&sd=2021-10-07

View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-nio-applovin-bilibili-levi-strauss-or-microstrategy-301395187.html

SOURCE InvestorsObserver

https://rt.prnewswire.com/rt.gif?NewsItemId=CG32759&Transmission_Id=202110070931PR_NEWS_USPR_____CG32759&DateId=20211007

comtex tracking

COMTEX_394735752/1005/2021-10-07T09:31:07

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.